viral
pathogen
result
imbal
viral
replic
host
immun
defenc
viru
lymphotrop
understand
pathogen
process
viral
diseas
becom
complic
viruslymphocyt
interact
alter
cell
integr
subsequ
induc
immunodefici
immun
system
play
import
role
outcom
acut
diseas
induc
mous
hepat
viru
type
use
attenu
escap
mutant
provid
tool
studi
role
viral
properti
involv
pathogen
select
mutant
virtu
resist
neutral
monoclon
antibodi
mab
order
studi
pathogen
properti
report
two
escap
mutant
attenu
pathogen
properti
accord
inocul
site
regard
surviv
time
abil
deplet
tand
bcell
subpopul
spleen
thymu
bone
marrow
suscept
balbc
mice
highli
attenu
mutant
could
induc
deplet
b
cell
follow
intraperiton
intranas
inocul
three
day
postinfect
less
attenu
mutant
howev
maintain
abil
hy
deplet
b
cell
follow
ip
inocul
describ
pathogen
contrast
deplet
cell
follow
inocul
induc
mutant
atthough
b
lineag
cell
decreas
use
mutant
enabl
us
examin
role
compart
immun
system
sinc
highli
attenu
mutant
induc
immunodefici
defin
immun
cell
deplet
whe
rea
less
attenu
mutant
maintain
abil
decreas
bcell
compart
inocul
result
discuss
regard
viruslymphocyt
interact
pathogen
process
result
imbal
viral
replic
host
immun
defenc
sisson
borysiewicz
cellular
resist
mice
infect
caus
particular
viru
may
indic
absenc
specif
genet
control
viral
permiss
factor
target
cell
brinton
nathanson
host
factor
includ
integr
submit
march
accept
septemb
cellular
humor
immun
defenc
helper
cytotox
lymphocyt
involv
viral
elimin
process
depend
upon
thymu
normal
lymphopoiesi
borysiewicz
sisson
raff
owen
specif
antivir
antibodi
play
import
role
viral
elimin
promot
antibodymedi
depend
cell
cytotox
complementmedi
cell
lysi
neutral
infecti
viral
particl
sisson
oldston
sisson
et
al
effici
humor
immun
respons
viral
infect
depend
normal
b
lymphopoiesi
take
place
bone
marrow
osmond
nossal
viru
lymphotrop
understand
pathogen
process
viral
diseas
complic
viruslymphocyt
interact
may
alter
cell
integr
induc
subsequ
immunodefici
mous
hepat
viru
type
hepatotrop
strain
coronaviru
inocul
mice
usual
follow
gener
infect
character
acut
hepat
necrosi
kill
anim
within
coupl
day
piazza
et
al
suscept
inbr
mice
hepat
diseas
depend
genet
control
host
factor
le
prevost
et
al
levyleblond
ef
al
levi
et
al
resist
aj
mice
undergo
subclin
infect
wherea
strain
balbc
fulli
suscept
fulmin
hepat
resist
aj
howev
becom
fulli
suscept
acut
diseas
follow
immunosuppress
treatment
dupuy
et
al
leray
et
al
intracerebr
inocul
lamontagn
et
al
x
aj
f
mice
howev
surviv
acut
phase
diseas
develop
humor
cellular
immunodefici
lead
paralysi
death
le
prevost
er
al
leray
et
al
differ
viru
titr
observ
target
organ
resist
suscept
mous
strain
lamontagn
et
al
despit
differ
histolog
lesion
vitro
replic
resist
infect
control
gene
express
haemopoiet
cell
matur
splenic
thymic
cell
levyleblond
et
al
dupuy
et
al
histopatholog
studi
reveal
lymphoid
organ
thymu
spleen
show
injuri
atrophi
suscept
mice
infect
pathogen
strain
lamontagn
et
al
splenic
b
cell
deplet
suscept
mice
lamontagn
et
al
lamontagn
et
al
addit
thymocyt
subpopul
decreas
thymu
infect
suscept
mice
lamontagn
jolicaeur
bone
marrow
preb
matur
b
cell
also
decreas
bone
marrow
termin
deoxytransferas
tdt
prob
cell
jolicmur
lamontagn
suscept
balbc
mice
associ
impair
earli
activ
immun
system
demonstr
failur
lymphocyt
prolifer
result
decreas
product
indzan
ef
al
genet
determin
sensit
infect
correl
viral
replic
macrophag
lamontagn
ef
al
mcnaughton
patterson
preb
blymphocyt
jolicczur
lamontagn
stromal
thymic
cell
complex
thymocyt
lamontagn
tand
bcell
deplet
report
elsewher
tcell
deplet
result
nonproduct
lytic
viral
replic
lymphoid
cell
contact
infect
thyrnic
stromal
cell
wherea
preb
b
cell
support
product
lytic
viral
replic
jolicmur
lamontagn
lamontagn
jolicceur
use
tool
studi
role
viral
properti
pathogen
attenu
escap
mutant
sever
viral
gene
includ
code
nucleocapsid
fleme
et
al
peplomer
protein
makino
ef
al
talbot
et
al
polymeras
lai
er
al
implic
determin
mhv
virul
protein
central
cellular
tropism
mhv
virul
respons
attach
viru
cell
receptor
point
mutat
gene
could
modifi
viral
pathogen
target
cell
select
mutant
virtu
resist
neutral
anti
monoclon
antibodi
mab
order
studi
pathogen
properti
show
pathogen
properti
two
escap
mutant
attenu
regard
surviv
time
depend
inocul
site
abil
deplet
tand
bcell
subpopul
spleen
thymu
bone
marrow
suscept
balbc
mice
balbc
mice
purchas
centr
delevag
de
animaux
de
laboratoir
cnr
orlean
franc
jackson
laboratori
bar
harbor
anim
test
either
upon
arriv
use
presenc
antimhv
antibodi
elisa
use
prepar
antigen
experi
anim
hous
steril
atmospher
forma
scientif
marietta
oh
pathogen
subclon
viru
passag
cell
mutant
select
pathogen
viru
presenc
proteinspecif
mab
respect
mab
chosen
select
escap
mutant
retain
partial
pathogen
properti
mab
abl
neutral
slightli
inhibit
cellular
fusion
protect
sensit
mice
infect
martin
et
al
virus
cultur
cell
vivo
pathogen
mortal
viru
titr
organ
determin
plaqueform
unit
pfu
intraperiton
ip
intranas
inject
immunolog
analys
perform
mice
receiv
pfu
group
mice
use
mortal
studi
measur
viral
titr
target
organ
group
three
mice
use
histopatholog
immunolog
studi
infect
brain
liver
kidney
lung
collect
minc
cultur
medium
fragment
frozen
thawedfrozen
three
time
centrifug
supernat
use
viral
suspens
viru
titrat
perform
plaqueform
method
onto
cell
less
pfug
consid
neg
result
celi
cell
continu
mous
fibroblast
cell
line
obtain
dr
r
anderson
univers
calgari
manitoba
canada
grown
eagl
mem
glutamin
mm
fc
fcetal
calf
serum
antibiot
penicillin
uml
streptomycin
pgml
gibco
laboratori
grand
island
ny
cell
use
propag
clone
viral
titrat
periton
exud
pe
cell
obtain
wash
periton
caviti
ml
contain
heparin
allen
hanburi
toronto
ontario
canada
pe
cell
seed
micropl
x
cellswel
cultur
co
h
infect
spleen
aseptica
ly
remov
minc
supplement
fc
glutamin
antibiot
thymus
asept
collect
teas
apart
use
needl
medium
fc
previous
describ
lamontagn
er
al
vitro
studi
spleen
thymic
lymphocyt
purifi
deposit
cell
suspens
lymphoprep
gradient
cedarlan
hornbi
ontario
canada
centrifug
cell
fraction
collect
wash
electron
count
coulter
counter
coulter
electron
hialeah
fl
bone
marrow
cell
obtain
flush
femor
shaft
four
time
ml
cold
medium
larg
particl
remov
sediment
cushion
ml
fc
min
cell
suspens
centrifug
resuspend
ml
medium
electron
count
coulter
counter
model
zm
coulter
electron
hialeah
fl
splenic
cell
label
follow
mab
fluorescein
isothiocyan
fitc
conjug
mab
cedarlan
hombi
ontario
canada
phycoetythrinconjug
mab
cedarlan
peconjug
polyclon
goat
antimous
p
chain
cedarlan
use
label
splenic
b
cell
singlecel
suspens
prepar
pool
organ
homogen
group
three
mice
x
cell
incub
optim
dilut
mab
min
wash
phosphatebuff
salin
pb
contain
bovin
serum
albumin
bsa
fmed
pb
ph
contain
formaldehyd
store
starkey
et
al
flow
cytometri
analysi
use
facscan
flow
cytomet
bectondickinson
mountain
view
ca
cell
gate
accord
forward
side
angl
light
scatter
gate
adjust
includ
discret
mononuclear
popul
five
thousand
cell
analys
per
sampl
thymocyt
similari
label
subpopul
record
doubl
label
p
chain
label
bone
marrow
prob
cell
perform
describ
park
osmond
briefli
bone
marrow
cell
incub
rat
mab
min
wash
incub
min
fitc
antirat
igg
cappel
biomed
malvem
pa
humidifi
atmospher
wash
centrifug
fc
gradient
cell
cytocentrifug
methanolacet
acid
fix
p
chain
label
use
tetramethyl
rhodamin
isothiocyan
tritc
conjug
antip
chain
cappel
biochem
min
cell
spot
wash
kept
overnight
pb
cytoplasm
p
cp
surfac
p
sp
preb
cpsp
b
cell
similarli
label
park
osmond
bone
marrow
sampl
x
cell
incub
min
ice
optim
dilut
fitc
antip
chain
cappel
biochem
label
cell
wash
twice
centrifug
fc
g
min
cell
resuspend
ml
pb
supplement
bsa
bone
marrow
cytocentrifug
fix
cytoplasm
p
chain
label
optim
dilut
tritc
antip
directli
cell
spot
incub
min
room
temperatur
humidifi
chamber
wash
four
time
kept
overnight
pb
slide
mount
medium
contain
glycerol
fisher
scientif
co
pb
ph
pphenylenediamin
fisher
scientif
co
fluoresc
microscop
equip
mercuri
lamp
phase
contrast
optic
use
slide
examin
cpsp
cpsp
blineag
cell
popul
diamet
least
cell
subpopul
measur
use
calibr
micromet
scale
percentag
label
cell
determin
count
total
cell
absolut
number
calcul
percentag
posit
label
cell
total
bone
marrow
count
statist
analysi
perform
use
student
test
studi
pathogen
tion
rout
b
mutant
viru
express
lower
virul
ip
result
indic
mutant
express
greatli
modifi
pathogen
properti
mutant
particularli
follow
inocul
attenu
mutant
ip
infect
balbk
mice
studi
mechan
involv
pathogen
process
attenu
mutant
level
viral
replic
variou
organ
evalu
group
balbk
mice
ip
infect
pathogen
attenu
mutant
viru
titr
liver
kidney
brain
lung
record
variou
time
postinfect
pi
fig
infecti
viral
particl
found
organ
pathogen
mice
earli
two
three
day
pi
signific
differ
viru
titr
howev
observ
ip
infect
mice
except
lung
fig
p
c
oool
higher
viru
titr
produc
follow
inocul
contrast
viral
replic
delay
organ
mice
ip
infect
mutant
six
day
longer
delay
six
twelv
day
viral
replic
organ
infect
mice
although
viru
titr
appear
sooner
lung
brain
fig
c
gross
examin
show
thymu
atrophi
pathogen
mice
lesser
extent
mice
result
suggest
correl
viral
pathogen
delay
viral
replic
thymic
atrophi
splenic
iymphoid
b
cell
ip
infect
balbk
mice
attenu
mutant
previous
demonstr
correl
pathogen
infect
deplet
splenic
b
cell
suscept
mice
lamontagn
er
al
mab
escap
mutant
may
attenu
lost
abil
induc
lymphoid
deplet
spleen
favour
develop
inflammatori
respons
infect
organ
verifi
hypothesi
percentag
absolut
number
splenic
subset
record
group
mice
ip
infect
either
pathogen
attenu
mutant
deplet
splenic
higher
ip
mice
fig
il
time
postinfect
day
level
cell
deplet
lower
mice
infect
attenu
mutant
deplet
higher
mice
contrast
thymocyt
subset
strongli
deplet
six
day
mice
infect
attenu
mutant
p
signific
decreas
subpopul
observ
thymic
deplet
thu
result
princip
decreas
immatur
cell
infect
mice
bone
marrow
bcell
subpopul
balbc
mice
ip
infect
attenu
mutant
splenicbcel
decreas
observ
mutantinfect
balblc
mice
may
reflect
inabl
bone
marrow
produc
matur
b
cell
viral
infect
previous
observ
infect
mice
jolicceur
lamontagn
infect
virus
p
c
deplet
less
evid
mice
infect
result
suggest
preb
b
cell
strongli
deplet
viral
infect
contrast
seen
viru
addit
bone
marrow
cell
similarli
deplet
result
shown
work
demonstr
relationship
pathogen
properti
attenu
mutant
deplet
tor
blineag
cell
spleen
thymu
bone
marrow
viral
pathogen
reflect
abil
viru
induc
clinic
diseas
death
mice
studi
mechan
viral
pathogen
two
approach
may
undertaken
analys
replic
virul
viru
variou
target
cell
resist
suscept
mous
strain
studi
alter
biolog
properti
attenu
viral
mutant
suscept
mous
strain
previous
work
first
approach
use
pathogen
resist
aj
suscept
mice
demonstr
correl
viral
pathogen
deplet
cell
lymphoid
organ
result
either
product
abort
viral
replic
jolicoeur
lamontagn
lamontagn
ef
al
lamontagn
jolicceur
use
neutral
escap
mutant
highlight
role
tor
bcell
deplet
pathogen
process
acut
hepat
pathogen
induc
deplet
splenic
thymic
bone
marrow
tor
blineag
cell
follow
ip
inocul
similar
decreas
blineag
cell
seen
mice
infect
less
attenu
mutant
wherea
splenic
thymocyt
subpopul
less
affect
highli
attenu
mutant
induc
bor
tlineag
cell
deplet
least
six
day
pi
liver
main
target
organ
infect
privileg
site
replic
le
prevost
ef
al
high
titr
pathogen
occur
rapidli
liver
ip
inocul
wherea
attenu
mutant
manifest
delay
occurr
viral
titr
ip
infect
mice
histopatholog
examin
reveal
dramat
effect
ip
pathogen
mice
particularli
liver
main
hepatocellular
necrosi
absenc
inflammatori
cell
evidenc
lesion
less
extens
infect
mice
fewer
inflammatori
cell
present
moder
liver
necrosi
foci
inflammatori
cell
howev
seen
mice
ip
inocul
result
shown
delay
product
viru
titr
thu
associ
less
extens
histopatholog
lesion
liver
low
transaminas
activ
measur
level
liver
necrosi
found
serum
mice
unlik
observ
mice
result
shown
addit
viral
replic
delay
mutant
inocul
thu
viral
pathogen
correl
time
appear
viru
tine
target
organ
rather
level
viral
titr
liver
brain
lung
kidney
correl
alreadi
observ
resist
aj
suscept
mice
spite
scarc
lesion
liver
resist
mice
lamontagn
jolicoeur
delay
viral
replic
may
explain
inabl
attenu
mutant
replic
primari
target
cell
perhap
ineffici
spread
infect
organ
preliminari
work
show
mutant
replic
poorli
pe
cell
contrast
viral
replic
suggest
macrophag
normal
play
antivir
role
follow
ip
infect
mutant
chang
role
macrophag
lymphoid
cell
barrier
infect
host
cell
target
viral
replic
strengthen
fact
genet
determin
resist
aj
mice
ip
infect
abrog
intracerebr
ic
inocul
lamontagn
et
al
interestingli
mice
surviv
day
pi
follow
ic
inocul
result
shown
contrast
infect
pathogen
suggest
mutant
highli
attenu
thu
unabl
replic
unidentifi
brain
target
cell
follow
inocul
mhv
strain
initi
replic
nasal
epithelium
rather
macrophag
appear
olfactori
pathway
within
brain
barthold
smith
goto
er
al
way
viru
persist
day
posterior
brain
wherea
elimin
within
day
nose
barthold
inform
avail
viral
persist
mechan
brain
follow
inocul
et
al
foci
observ
liver
attenu
virusinfect
mice
contrast
pathogen
mice
suggest
viru
mutant
replic
liver
cell
could
lost
abil
thwart
natur
immun
cell
respons
previous
demonstr
mutant
replic
endotheli
cell
mutant
kuppfer
cell
hepatocyt
martin
et
al
hand
correl
pathogen
atrophi
spleen
thymu
indic
immun
cell
may
instead
play
import
role
pathogen
process
acut
diseas
lamontagn
ef
al
furthermor
involut
thymu
spleen
report
mice
ic
infect
lethal
dose
neurotrop
mhvjhm
strain
follow
ip
inocul
knobler
er
al
suggest
primari
target
cell
depend
inocul
site
play
import
role
pathogen
replic
viru
spread
infect
level
attenu
mutant
correl
abil
deplet
splenic
b
cell
highli
attenu
mutant
induc
rapid
deplet
b
cell
follow
ip
inocul
less
attenu
mutant
howev
maintain
abil
deplet
b
cell
follow
ip
inocul
describ
except
deplet
cell
follow
inocul
use
mutant
enabl
us
examin
role
compart
immun
system
consid
highli
attenu
mutant
induc
immunodefici
defin
immun
cell
deplet
wherea
less
attenu
mutant
maintain
abil
induc
decreas
bcell
compart
inocul
mechan
involv
differ
pathogen
properti
neutral
escap
mutant
yet
elucid
previous
demonstr
major
differ
nonpathogen
viru
pathogen
inabl
replic
thymic
stromal
cell
b
lymphocyt
jolicceur
lamontagn
lamontagn
jolicczur
preliminari
result
indic
mutant
induc
bcell
lysi
vitro
contrast
virus
correl
viral
pathogen
vitro
viral
replic
variou
target
cell
frequent
report
explain
genet
resist
variou
mhv
strain
boyl
et
al
knobler
ef
al
lamontagn
et
al
mcnaughton
ef
al
mhv
pathogen
princip
carri
gene
code
rna
polymeras
viral
glycoprotein
respons
attach
viru
cellsurfac
receptor
fleme
ef
al
lai
er
al
talbot
et
al
hand
immunodomin
site
respons
bind
neutral
antibodi
locat
glycoprotein
particularli
subunit
domain
also
identifi
near
proteolyt
cleavag
site
along
globular
section
subunit
daniel
et
al
routledg
ef
al
contrast
virusmedi
fusion
activ
locat
site
differ
neutral
epitop
shown
bind
site
sever
mab
collin
et
al
routledg
et
al
mab
use
select
attenu
mutant
abl
neutral
high
dilut
slightli
inhibit
cellular
fusion
protect
sensit
mice
pathogen
infect
martin
et
al
suggest
virus
modifi
site
includ
neutral
epitop
locat
near
fusion
site
probabl
portion
viral
glycoprotein
daniel
et
al
variant
mhvjhm
may
gener
larg
delet
point
mutat
gallagh
et
al
routledg
et
al
differ
size
mrna
code
protein
size
protein
detect
mutant
pathogen
viru
suggest
neutralizationresist
variant
express
point
mutat
neutral
site
induc
conform
chang
daniel
et
al
martin
er
al
point
mutat
protein
total
explain
pathogen
properti
viru
sinc
conform
chang
protein
may
affect
viral
tropism
one
target
cell
without
alter
tropism
target
cell
dalziel
et
al
fleme
et
al
viral
pathogen
complex
properti
modul
viral
tropism
sever
target
cell
hand
studi
viral
pathogen
dissoci
immun
respons
mechan
variou
target
organ
integr
immun
system
essenti
mount
effici
respons
elimin
viral
product
variou
infect
cell
correl
observ
work
pathogen
attenu
mutant
shed
light
role
b
lymphocyt
target
cell
viral
replic
consequ
virusinduc
immunodefici
vial
replic
immun
cell
may
also
respons
decreas
number
cell
involv
natur
resist
viral
infect
ie
macrophag
nk
cell
second
stage
b
lymphocyt
respons
mount
effici
cellular
humor
immun
respons
effect
clearanc
viral
infect
brain
requir
lymphocyt
also
unidentifi
bone
marrow
cell
williamson
stohlman
addit
demonstr
elsewher
hepat
result
lytic
viral
replic
hepatocyt
rather
correl
directli
spontan
tlymphocyteinstruct
express
procoagul
monokin
exhibit
prothrombincleav
activ
observ
suggest
induc
cellular
injuri
activ
coagul
cascad
microcircul
damag
levi
abecassi
vigor
procoagul
activ
respons
observ
splenic
mononuclear
cell
suscept
balbc
mice
wherea
activ
detect
cell
resist
aj
mice
dindzan
et
al
result
indic
tropism
macrophag
lymphoid
cell
subpopul
may
alter
product
variou
cytokin
involv
inflammatori
respons
pathogen
process
work
progress
determin
permiss
variou
tand
bcell
subpopul
replic
attenu
mutant
identifi
role
primari
cell
target
outcom
infect
depend
inocul
site
levolut
de
la
maladi
induit
chez
la
souri
par
un
viru
lymphotrop
le
viru
de
lhtpatit
murin
de
type
depend
de
lintegrit
du
system
immunitair
lutilis
de
mutant
dtchappement
est
un
moyen
par
lequel
il
est
possibl
de
determin
limport
du
lymphotropism
dan
le
processu
pathogtniqu
nou
avon
selectionn
de
viru
mutant
en
fonction
de
leur
resist
la
neutralis
par
de
anticorp
monoclonaux
et
nou
avon
analys
leur
propritt
pathogtniqu
nou
avon
montrt
que
lattenu
de
mutant
obtenu
ctait
en
relat
avec
leur
capacitt
dinduir
une
diminut
de
souspopul
de
lymphocyt
et
b
dan
la
rate
la
moell
osseus
et
le
thymu
de
souri
balbc
le
mutant
fortement
attcnuc
ninduit
aucun
diminut
de
lymphocyt
apr
troi
jour
dinfect
b
la
suit
dune
inocul
intraperitoneal
ip
ou
intranasal
